Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
Authors
Matic Setina
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Eva Setina
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Ziga Doljak
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Katja Goricar
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Vita Dolzan
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Viljem Kovac
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 403 - 411
Submitted on: Jun 15, 2025
Accepted on: Jul 19, 2025
Published on: Sep 5, 2025
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2025 Matic Setina, Eva Setina, Ziga Doljak, Katja Goricar, Vita Dolzan, Viljem Kovac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.